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Generation and validation of novel 
adeno-associated viral vectors for 
the analysis of Ca2+ homeostasis in 
motor neurons
Rosa Pia Norante1, Maria Lina Massimino2, Paolo Lorenzon1,4, Agnese De Mario1, Caterina 
Peggion1, Mattia Vicario1, Mattia Albiero  3, Maria Catia Sorgato1,2, Raffaele Lopreiato1 & 
Alessandro Bertoli1
A finely tuned Ca2+ homeostasis in restricted cell domains is of fundamental importance for neurons, 
where transient Ca2+ oscillations direct the proper coordination of electro-chemical signals and overall 
neuronal metabolism. Once such a precise regulation is unbalanced, however, neuronal functions and 
viability are severely compromised. Accordingly, disturbed Ca2+ metabolism has often been claimed as 
a major contributor to different neurodegenerative disorders, such as amyotrophic lateral sclerosis that 
is characterised by selective motor neuron (MN) damage. This notion highlights the need for probes for 
the specific and precise analysis of local Ca2+ dynamics in MNs. Here, we generated and functionally 
validated adeno-associated viral vectors for the expression of gene-encoded fluorescent Ca2+ indicators 
targeted to different cell domains, under the transcriptional control of a MN-specific promoter. We 
demonstrated that the probes are specifically expressed, and allow reliable local Ca2+ measurements, 
in MNs from murine primary spinal cord cultures, and can also be expressed in spinal cord MNs in vivo, 
upon systemic administration to newborn mice. Preliminary analyses using these novel vectors have 
shown larger cytosolic Ca2+ responses following stimulation of AMPA receptors in the cytosol of primary 
cultured MNs from a murine genetic model of ALS compared to the healthy counterpart.
Ca2+ ions play a fundamental role in all cell types by controlling an impressive number of signalling events. 
Therefore, a precise control of Ca2+ homeostasis in the cytosol and other cell compartments/organelles – per-
formed by several systems like pumps, channels, transporters and Ca2+-buffering proteins – is essential for cell 
physiology. In neurons, local Ca2+ fluctuations have a key physiologic impact, by controlling the spatiotemporal 
pattern of electrochemical signals, neurite outgrowth, synaptic plasticity and the patterning of dendritic spines, 
which is of key importance in the neurochemical/neuroanatomical establishment of learning and memory, and 
cell survival. Not surprisingly, small changes in Ca2+ dynamics can lead to pathological conditions1, and derange-
ment of Ca2+ homeostasis has been frequently indicated as a major contributor to the onset of various neurode-
generative disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s disease2.
Among neurons, motor neurons (MNs) are particularly sensitive to noxious cell Ca2+ overloads because they 
possess low levels of Ca2+-buffering proteins3, 4, and express high levels of Ca2+-permeable α-amino-5-methyl-3- 
hydroxisoxazolone-4-propionate (AMPA) receptors that lack the GluR2 subunit. Such an architecture makes 
AMPA receptors more vulnerable to dysregulation of intracellular Ca2+ homeostasis and excitotoxicity5. Not 
surprisingly, perturbed Ca2+ homeostasis has been claimed as a major actor in the pathogenesis of different MN 
disorders, such as amyotrophic lateral sclerosis (ALS)6, 7 and spinal muscular atrophy8. The above notions high-
light the need for molecular tools, such as suitable Ca2+ indicators, for the specific and precise analysis of Ca2+ 
movements in different sub-cellular compartments of MNs.
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There are two major classes of Ca2+ indicators: chemical probes and gene-encoded calcium indicators (GECI). 
The first ones are hybridizations of small Ca2+-chelating molecules and a fluorophore. This class of probes include 
fura-2, quin-2, indo-1 and fluo-3, which were the first indicators used for Ca2+ measurements in cells9. A second 
class of probes is that of GECI, which includes different types of engineered proteins such as green fluorescent 
protein (GFP)-derived fluorescent probes, bioluminescent probes and fluorescence (or Förster) resonance energy 
transfer (FRET)-based indicators. A clear advantage of these probes is that – at difference from chemical indica-
tors – they can be genetically targeted to different cell domains/compartments for local Ca2+ measurements. On 
the other hand, they suffer from the difficulty to be efficiently expressed in cells, in particular in primary neurons. 
Such a drawback, however, can be now easily overcome by use of viral expression vectors10–12.
Cameleon probes are based on FRET, a well-known quantum mechanical process consisting in the energy 
transfer from an exited fluorescent donor to an acceptor fluorophore placed in close proximity. Therefore, when 
FRET occurs, an increased fluorescence of the acceptor, together with a decreased fluorescence of the donor can 
be observed and quantified. In cameleons, the FRET donor and acceptor are GFP-derived fluorescent proteins 
separated by a Ca2+-sensing domain, consisting of calmodulin (CaM) and a CaM-binding peptide derived from 
the myosin light chain kinase M13. Upon Ca2+ binding to this domain, the FRET donor and acceptor are brought 
in close spatial proximity, thereby allowing FRET to occur. To date, the most used GFP-modified proteins in 
cameleons are the yellow fluorescent protein (YFP, acting as donor) and the cyan fluorescent protein (CFP, accep-
tor). In last years, several studies based on site-directed mutagenesis have led to the generation of improved came-
leon Ca2+ probes, by increasing the brightness of the FRET acceptor in response to Ca2+ fluctuations, reducing 
the possible competitive effect of endogenous CaM, and extending the affinity of cameleons for Ca2+ to render the 
probes suitable for Ca2+ measurements in different cell districts. In particular, different kinds of cameleon exist 
(classified as D1, D2, D3 and D413) covering a wide Kd range for Ca2+ that allow scientists to choose the best probe 
for the specific cell compartment under study13–15.
In this work, we have generated and functionally validated adeno-associated viral (AAV)-based vectors for the 
expression of cameleons targeted to different cell domains [i.e., cytosol, mitochondrial matrix, or endoplasmic 
reticulum (ER) lumen] under the transcriptional control of a MN-specific promoter. We demonstrate that such 
probes are specifically expressed in MNs (and not in other cell types) in primary cell cultures from the mouse 
spinal cord, and that they allow reliable Ca2+ measurements in the target cell compartment. Pilot experiments 
also demonstrate altered Ca2+ homeostasis in the cytosol of primary MNs from a genetic model of ALS, and that 
the generated AAV expression vectors can be suited for the in vivo expression of cameleons in spinal cord MNs 
in mice.
Results
Given the plausible implication of perturbed Ca2+ homeostasis in the pathogenesis of MN diseases6–8, in this 
study we sought to generate and validate expression systems for GECI that were suited for the assessment of 
local Ca2+ fluctuations in MNs. To this purpose, we have engineered AAV plasmids (pAAV) for the expression 
of cameleon probes targeted to the cytosol (pAAV-[Hb9_AB]-D1cpv), the mitochondrial matrix (pAAV-[Hb9_
AB]-4mtD3cpv) and the ER lumen (pAAV-[Hb9_AB]-D4ER), under the control of a MN-specific, homeobox 
Hb9-derived, promoter (Supplementary Fig. S1). The cameleon probes of choice have great ratiometric sensitivity 
and large dynamic range, thereby allowing to detect small changes in Ca2+ concentration over the noise in the 
target compartment13.
To validate such vectors for the specific recording of Ca2+ fluxes in MNs, we firstly analysed the expression 
of our AAV-driven probes in the immortalised NSC-34 cell line that – when properly differentiated – displays 
several typical properties of MNs16, 17, including the transcriptional activation of the Hb9 gene18. We therefore 
checked the expression of the three cameleon probes in NSC-34 cells, transduced with the AAV vectors, either 
cultured under proliferating conditions or induced to differentiate by treatment with retinoic acid. Under the 
latter culturing conditions, all cells were successfully differentiated into a MN phenotype, as determined by both 
morphological observations (Fig. 1, bright-field images of panels D,H,L) and immunoblot assessment of the MN 
marker choline acetyl-transferase (Supplementary Fig. S2). We observed that all cameleons were abundantly pres-
ent in differentiated cells (>97% cells expressing the probes), but completely absent in cells under active prolif-
eration, suggesting that the Ca2+ probes were specifically expressed in cells resembling a MN phenotype (Fig. 1).
We then analysed by confocal microscopy the expression of cameleons in primary cultures from mouse spinal 
cord. After 12 days of growth, such cultures contained different cell types, including mature MNs resembling 
those present in vivo, both morphologically and for the expression of specific molecular markers, such as the 
neurofilament protein SMI32, with 4.9% ± 0.7% of SMI32-positive MNs over total cells (n = 35). As described in 
Fig. 2, after transduction of such cell cultures with the AAV vectors, the cameleons (green signal, panels A,E,I) 
were present in SMI32-positive cells (red signal, panels B,F,J), while in no case other cell types (highlighted by 
nuclear staining, blue signal, panels C,G,K) were positive for the expression of cameleons, providing evidence that 
the Hb9 promoter-driven expression of the Ca2+ probes is specific for MNs (merge, panels D,H,L). In addition, 
the transduction efficiency of MNs was rather high, given that in all cases more than 70% of SMI32-positive cells 
were also positive for the expression of the cameleon probes (Supplementary Fig. S3).
The MN-specific expression of the Ca2+ probes was further reinforced by the finding that the AAV vectors 
were unable to drive the expression of the mitochondria-targeted cameleon in primary cultures of cortical, hip-
pocampal or cerebellar granule neurons, or spinal astrocytes (Supplementary Fig. S4).
Although the correct sub-cellular targeting of the used cameleon chimeric constructs has been already 
demonstrated in different cell paradigms14, 19, 20, we checked that the probes had the expected localisation also 
in primary MNs. As shown by the confocal microscopy z-stack reconstructions of Fig. 3, each cameleon (panels 
A,D,G) largely co-localised (yellow signal, merged images of panels C,F,I) with immuno-labelled markers of the 
corresponding target compartment, i.e., glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for the cytosol 
www.nature.com/scientificreports/
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(panel B), Tom20 for mitochondria (panel E), and calreticulin for the ER lumen (panel H), indicating that the 
probes are correctly processed and delivered to the target site in AAV transduced MNs.
ALS is a fatal neurodegenerative disorder that occur on sporadic or genetic grounds, leading to a selective 
and progressive loss of MNs in the spinal cord, brainstem and cerebral cortex, thereby resulting in severe motor 
deficits and – eventually – to death21, 22. Since perturbations of Ca2+ homeostasis in MNs have been often claimed 
as a crucial event in disease progression7, 23 we tested the applicability of the novel Ca2+-probe encoding vectors 
to the comparative analysis of local Ca2+ homeostasis in MNs from an ALS mouse model [i.e., mice expressing 
the ALS-related G93A mutant of human (h) SOD1 and the healthy counterpart (hSOD1(WT)-expressing mice)].
In this work we did not calculated absolute Ca2+ concentrations, which, however, could be determined by 
suitable calibration procedures13. Instead, we simply reported the ratio between the acceptor and the donor flu-
orescence of the FRET-based probes, which is, nevertheless, sufficient for comparative analyses. Such experi-
ments demonstrated that all cameleon probes were functional, and indicated that hSOD1(G93A)-expressing MNs 
have larger cytosolic Ca2+ transients following AMPA stimulation, compared to SOD1(WT) MNs (Fig. 4A,B). 
Comparable results for both basal and peak Ca2+ levels were obtained using the chemical Ca2+ indicator Fura-2 
(Supplementary Fig. S5), further supporting the suitability of the AAV-mediated, Hb9_AB-driven, expression of 
the cameleon probes for reliable Ca2+ measurements in MNs. Conversely, the mitochondrial targeted cameleon 
revealed no significant difference in AMPA-stimulated Ca2+ fluxes in the mitochondrial matrix (Fig. 4C,D). Also 
the ER-targeted cameleon was properly functioning, allowing the measurement of ER Ca2+ discharge upon stim-
ulation with caffeine, which, however, evidenced no difference between MNs with the two genotypes (Fig. 4E,F).
Finally, we probed if the developed AAV-based vectors were suited for the in vivo expression of the cameleon 
probes. To this purpose, we injected the AAV vector coding for the mitochondrial or the ER cameleon into the 
superficial temporal vein of newborn mice, and (4 weeks later) we evaluated the expression of the probes in spinal 
cord sections. By use of a fluorescence stereo-microscope, we observed an intense and diffuse signal in tissue 
samples of mice transduced with either the mitochondrial (Fig. 5A–C) or the ER (Fig. 5D–F) cameleon, providing 
a transduction ratio (cameleon-positive cells over total cells) of 16% ± 4% and 9.8% ± 1.7%, respectively (n = 3). 
That the AAV-based expression system of cameleons was specific for MNs also in vivo was demonstrated by the 
immunostaining of the MN marker SMI32 in spinal cord slices from ER cameleon-infected mice, followed by 
confocal microscopy (Fig. 5G–J).
Discussion
Recombinant AAVs are a powerful means for in vivo gene delivery24, 25 and for the transduction of primary cell 
cultures that are particularly hard to transfect, such as neurons26, 27. AAVs display low cytotoxicity and immu-
nogenicity, are safe for the operator, and are suitable for long term gene expression in non-dividing cells with 
relatively high gene delivery efficiency, depending on the cell type28.
In this work, we have generated pAAV plasmids encoding cameleon Ca2+ probes, genetically targeted to dif-
ferent cell compartments, under the transcriptional control of a MN-specific promoter. Given that AAV vectors 
has limited cloning capacity (i.e., large plasmids can hardly be packaged into AAV viral particles), we have chosen 
a genetically engineered minimal promoter of the Hb9 gene (Hb9_AB), which is about 550 bp in length and 
has already been demonstrated to specifically drive the expression of a transgene into MNs, both in vitro and in 
vivo29. For the preparation of the viral particles, we have chosen the AAV9 serotype because of its broad tropism, 
Figure 1. The cameleon probes under the control of the Hb9-derived promoter are expressed in differentiated, 
but not in proliferating, NSC-34 MN cells. NSC-34 cells were infected with the AAV vectors coding for the 
Hb9_AB-driven, MN-specific, cameleon probes targeted to the cytosol (D1cpv, panels A–D), the mitochondrial 
matrix (4mtD3cpv, panels E–H), or the ER lumen (D4ER, panels I–L), and cultured under non-differentiating 
(proliferating, panels A,B,E,F,I,J) or differentiating (by growth in the presence of retinoic acid 5 μM, 192 h, 
panels C,D,G,H,K,L) conditions. Fluorescence (λex = 488 nm, λem = 526/550 nm) and differential interference 
contrast (DIC) micrographs of representative fields were taken with a suited microscope equipped with a CCD 
camera. No fluorescent cell was observed in non-differentiated NSC-34 cultures, while the fluorescent Ca2+ 
probes were expressed in cells differentiated towards a MN phenotype. Shown data are representative of at least 
3 independent experiments yielding comparable results. Scale bar = 20 µm.
www.nature.com/scientificreports/
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including the capacity to target neurons28. We have demonstrated that the engineered AAV vectors are suitable 
for the specific expression of the cameleons targeted to the cytosol, the mitochondrial matrix and the ER lumen 
of MNs from spinal cord primary cultures of mice, and allow measuring Ca2+ responses to proper stimuli in such 
cellular districts. These vectors have several advantages with respect to other expression systems or the use of 
ubiquitous promoters. Indeed, they allow Ca2+ measurements in single primary MNs with no need for difficult 
Figure 2. The cameleon probes are selectively expressed in motor neurons in mouse spinal cord primary 
cultures. Primary cell cultures from the mouse spinal cord were transduced with the AAV vectors coding for 
the cameleons targeted to the cytosol (panels A–D), the mitochondrial matrix (panels E–H) or the ER lumen 
(panels I–L). After 12 days of culturing, cells were fixed, permeabilised, immunostained with an antibody to the 
motor neuron (MN) marker SMI32, and then counter-stained with the nuclear fluoro-probe Hoechst 33342. 
Confocal microscope images of cells were then collected after excitation at either λ = 488 nm for visualising the 
fluorescent Ca2+ probes (green signal, panels A,E,I), λ = 543 nm for visualising SMI32-positive cells (red signal, 
panels B,F,J), or λ = 405 nm for visualising the nuclei of all cells (blue signal, panels C,G,K). Merging of the three 
fluorescent channels (panels D,H,L) shows that only SMI32-positive MNs express the Ca2+ probes (see also 
Supplementary Fig. S3). Scale bar = 20 µm.
www.nature.com/scientificreports/
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and time-consuming MN purification steps. In addition, MN Ca2+ measurements can be performed in a more 
physiologic environment, containing glial cells and other neuronal types, compared to pure MN cultures.
Although SMI32-positive MNs were less than 5% of total cells in our primary spinal cord cultures, the trans-
duction efficiency ( >70%) of MNs by the AAV-mediated infection system was largely sufficient for single cell 
analyses. Indeed, the transduction rate was much higher than that achieved by transfection with plasmidic vec-
tors, with which cameleon-expressing MNs were rarely found in each preparation, also when using a constitutive 
and ubiquitous (cytomegalovirus), or the pan-neuronal human synapsin1 (hSyn), promoter (data not shown). In 
addition, in our experimental setting, a substantial number of SMI32-positive cells contained the Ca2+ probes at 
an expression level that easily allowed single cell recordings of Ca2+ dynamics.
Among GECI, the ratiometric cameleon probes have several advantages, including low risk of artifacts, high 
sensitivity, good dynamic range, and the possibility to provide absolute Ca2+ concentration values upon proper 
calibration procedures13. The ratiometric nature of these Ca2+ indicators, as in the case of chemical probes such 
as Fura-2, prevents any differences due to level of expression or cell thickness. In addition, engineering of mutant 
cameleons have provided researcher with several cameleons displaying a wide range of Kd for Ca2+, thereby allow-
ing reliable measurements of basal Ca2+ levels and evoked Ca2+ movements depending on the target cell compart-
ment, the cell type and the desired stimulation protocol14, 19.
Figure 3. The cameleon probes correctly localize to the target sub-cellular compartment in primary MNs. 
Primary cell cultures from the mouse spinal cord were transduced with the AAV vectors coding for the 
cameleons targeted to the cytosol (panels A–C), the mitochondrial matrix (panels D–F) or the ER lumen (panels 
G–I). After 12 days of culturing, cells were fixed, permeabilised, and immunostained with antibodies to proteins 
present in the cytosol (GAPDH, panel B), mitochondria (Tom-20, panel E), or the ER (calreticulin, panel H). 
Images report the merged reconstruction of complete z-stacks of cells, collected by a confocal microscope 
after excitation at either λ = 488 nm for visualising the fluorescent Ca2+ probes (panels A,D,G), or λ = 543 nm 
for visualising the immuno-labeled proteins (panels B,E,H). The remarkable fluorescence overlapping of each 
targeted cameleon and the corresponding marker immunosignal (panels C,F,I) demonstrates the correct sub-
cellular targeting of all used Ca2+ probes. Scale bar = 10 µm.
www.nature.com/scientificreports/
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Figure 4. AMPA stimulation results in higher cytosolic Ca2+ transients in primary spinal cord MNs from 
ALS mice than in the healthy counterpart. Primary spinal cord cultures from hSOD1(WT) or hSOD1(G93A) 
mice were transduced with the AAV vectors coding for the cameleon probes targeted to the cytosol (panels 
A,B), the mitochondrial matrix (panels C,D) or the ER lumen (panels E,F). After 12 days of culturing, FRET 
measurements were performed on single MNs expressing the different Ca2+ probes using a computer-assisted 
fluorescence microscope equipped with a suitable system for double-wavelength recordings. The ratio (R) 
between the FRET acceptor and donor was calculated by the data acquisition software, allowing the comparison 
of Ca2+ mobilisation following stimulation with AMPA (25 μM in the presence of 2 mM CaCl2, for the cytosol 
and the mitochondrial matrix) or caffeine (100 μM, for the ER) at the time-points indicated by arrows, between 
hSOD1(WT) or hSOD1(G93A) MNs. Panels A, C, E report average traces of the Ca2+ dynamics (for the sake 
of clarity, error bars are not reported), while bar diagrams of panels B,D,F report the mean difference between 
FRET ratios (ΔR = Rpeak − Rbaseline) following the indicated stimulus in the three cell compartments. While 
no difference was recorded in Ca2+ movements in the mitochondrial matrix or the ER lumen, the cameleon-
based approach highlighted a significantly higher Ca2+ response following AMPA stimulation in the cytosol 
www.nature.com/scientificreports/
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For cytosolic Ca2+ measurements we have used the archetypal D1-based probe30, which allowed us to measure 
cytosolic fluctuations of the ion in MNs following AMPA stimulation.
Mitochondria-Ca2+ interplay is essential for cell physiology. On the one hand, the fine regulation of mitochon-
drial Ca2+ controls ATP production, because different mitochondrial enzymes rely on local Ca2+ concentration 
for their activity. On the other hand, mitochondria are a major Ca2+-buffering system avoiding noxious cytosolic 
Ca2+ overloads. While it is assumed that resting mitochondrial Ca2+ concentration is in the order of 10−1 μM, 
upon stimulation promoting Ca2+ entry from the extracellular space or its release from the ER, Ca2+ levels in 
the mitochondrial matrix may reach up to 102 μM, depending on the cell type and the stimulus31. Therefore, we 
have selected the 4mtD3cpv cameleon that, for its Kd and dynamic range, has been proved useful for measuring 
mitochondrial Ca2+ dynamics13.
Finally, for the measurements of Ca2+ homeostasis in the ER lumen, we have chosen the recently generated 
D4ER probe14 that has been proved useful for comparative Ca2+ measurements in an experimental setting of 
neurodegenerative disorders32.
Notably, cameleons are mostly expressed in SMI32-positive α-MNs, enriched in the anterior ventral horn of 
the spinal cord33, 34, which are particularly vulnerable to (AMPA-mediated) excitotoxic challenge and ALS-related 
damage6, 7. Thus, to prove the efficacy of the probes to monitor local Ca2+ fluctuations in MNs, we have compared 
the response of MNs from mice expressing the ALS-related hSOD1(G93A) mutant, or the hSOD(WT)-expressing 
counterpart, to selected stimuli. In particular, because MNs express high levels of AMPA receptors through 
which they process strong glutamatergic inputs, and because excitoxicity has been proposed to contribute cru-
cially to MN injury in ALS, probably as a consequence of glutamate-triggered Ca2+ overload7, 35, we investi-
gated Ca2+ responses to AMPA stimulation. The cytosolic and mitochondrial probes allowed the assessment of 
AMPA-mediated cell Ca2+ responses, thereby providing proof-of-principle for the functional application of these 
tools. Such conclusion is further corroborated by the finding that Fura-2-based measurements provided very 
similar results for cytosolic Ca2+ responses to AMPA stimulation. In addition, both cameleon- and Fura-2-based 
strategies underscored a larger cytosolic Ca2+ response in ALS MNs compared to the healthy controls supporting 
the idea that Ca2+ overloads may be involved in ALS MN damage7, 36. Surprisingly, in spite of increased cytosolic 
Ca2+ load, no difference was observed in the mitochondrial matrix, suggesting a possible deficit of mitochondrial 
Ca2+ upload in ALS MNs that deserves further investigation. With this respect, it must be noted that, to the best 
of our knowledge, no direct measuring of mitochondrial Ca2+ fluctuations under our experimental settings has 
been previously reported, and that mitochondrial Ca2+ handling deficits could be stage-dependent during ALS 
disease course37. We also provided evidence that the ER cameleon was properly functioning and monitored the 
ER Ca2+ discharge promoted by caffeine38, although no difference was observed between the two SOD1 geno-
types. These notions further highlight the importance of the here-presented tools for deepening our understand-
ing of disease-associated local Ca2+ alterations in MNs, in in vitro and in vivo models.
In conclusion, the novel vectors we generated in this work allowed for the first time to directly monitoring 
local Ca2+ fluctuations in sub-cellular compartments of primary mouse MNs, thereby providing valuable and 
versatile tools for expanding our knowledge on Ca2+-related pathogenic routes in ALS and other neuromuscular 
diseases. With this respect, it is worth underlining that other GECI-encoding sequences can be easily cloned into 
the generated MN promoter-containing pAAV scaffold, thus further increasing the toolset of Ca2+ probes with 
different properties (e.g., Kd) for suitable Ca2+ measurements under different experimental protocols in MNs.
Importantly, we also provided evidence that the AAV vectors can drive the selective in vivo expression of 
the Ca2+ probes in MNs. This result was achieved by systemic administration of the virus, which is by far less 
invasive and arduous than local injection in the spinal cord of live mice. Thus, by means of suitable fluorescence 
microscopy equipment (e.g., two-photon microscopy), this system could be used for Ca2+ measurements in more 
physiologic environments than primary cultures, such as tissue slices or even live animals.
Materials and Methods
Plasmid construction. Multiple pAAVs have been generated, for the expression of the FRET-based cameleon 
Ca2+ probes targeted to different cellular compartment (i.e. cytosol, mitochondrial matrix and ER lumen13, 14, 19, 20  
under the control of either a minimal promoter (Hb9_AB) derived from the (MN)-specific promoter of the Hb9 
gene29, or the pan-neuronal hSyn promoter.
Firstly, the sequence coding for the cytosolic probe (D1cpv)19, previously isolated by BamHI-EcoRI cleav-
age of a pcDNA3-D1cpv plasmid (kindly provided by Dr. Roger Tsien, University of California, San Diego, 
USA)13, 19, was inserted into the BamHI-EcoRI sites of the pAAV-[hSyn]-ChR2/EYFP vector (Addgene, cat. # 
26973) (Supplementary Fig. S1, panel A) by T4 DNA ligase, thus providing the pAAV-[hSyn]-D1cpv plasmid 
(Supplementary Fig. S1, panel B).
For the generation of the ER lumen-targeted expression vector, the sequence coding for the D4ER cameleon14 
was amplified by PCR using the pcDNA3-D4ER plasmid (kindly provided by Dr. Paola Pizzo, Dept. of Biomedical 
Science, Univ. of Padova) as template, and the primers ER-KpnI-F and ER-HindIII-R (sequences are reported in 
the Supplementary Information). The PCR product was digested with KpnI-HindIII, and purified DNA frag-
ments were ligated into the KpnI-HindIII sites of the pAAV-[hSyn]-ChR2/EYFP as indicated above, generating 
the pAAV-[hSyn]-D4ER plasmid (Supplementary Fig. S1, panel B).
of MNs expressing the ALS-related hSOD1(G93A) mutant compared to the hSOD1(WT) counterpart. Data 
are reported as mean ± standard error of the mean (SEM); n = 6 (A and B), 12 (C and D), 9 (E and F), for each 
genotype, from at least 3 different MN cultures for each condition; *p < 0.01, Student’s t-test.
www.nature.com/scientificreports/
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Subsequently, the [hSyn] promoter in the obtained plasmids was substituted with the sequence coding for the 
∼550 bp MN specific promoter [Hb9_AB], which was previously amplified by PCR using the Bg.Hb9_AB_GFP 
plasmid29 (kindly provided by Dr. Caterina Bendotti, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, 
Milano, Italy) as template, and primers AB-MluI-F and AB-KpnI-R (sequences are reported in the Supplementary 
Information). The PCR product, subjected to MluI-KpnI cleavage and purified, was then ligated into both pAAV-
[hSyn]-D1cpv and pAAV-[hSyn]-D4ERcpv plasmidic fragments digested with the same enzymes.
Concurrently, the pAAV vector encoding the mitochondrial matrix-targeted 4mtD3cpv13 cameleon was 
obtained by replacing the [hSyn] promoter sequence of the pAAV-[hSyn]-4mtD3cpv plasmid (a generous gift by 
Dr. Paola Pizzo, Dept. of Biomedical Science, Univ. of Padova) with the [Hb9_AB] sequence, by using the MluI 
and KpnI restriction sites.
After transformation of E. coli TOP10 cells with the generated constructs and selection of positive clones, 
recombinant plasmids were amplified and validated by sequencing. All enzymes were from New England Biolabs, 
excepted the high-fidelity DNA polymerase (KAPA Biosystems), and DNA primers (Life Technologies). DNA 
manipulations have been performed accordingly to standard methods39 and to manufacturer’s instructions. 
Detailed maps and plasmids sequences are all available upon request to the corresponding author.
AAV viral particles (AAV9 serotype) were produced by Vigene Biosciences, providing viral titers ranging from 
2 × 1013 to 10 × 1013 GC/ml (see Supplementary Information).
Animals. Tg mice expressing WT, or the ALS-related G93A mutant of hSOD1, (B6SJL(Tg-SOD1)2Gur/J and 
B6SJL(Tg-SOD1*G93A)1Gur/J mice, respectively) were purchased from The Jackson Laboratories. The colo-
nies were maintained by breeding hemizygote (Tg) males to wild-type B6SJLF1/J hybrid females. Embryos and 
newborns were genotyped (as described in Supplementary Information), and used for subsequent experiments. 
All aspects of animal care and experimentation were performed in compliance with European and Italian (D.L. 
Figure 5. The MN promoter-driven cameleons can be efficiently and specifically expressed in MNs after 
transduction of mice with the AAV vectors in vivo. Neonatal mice (P1) were injected into the temporal vein 
with AAV vectors encoding the mitochondrial (panels A–C) or the ER (panels D–J) cameleon. Mice were 
sacrificed 4 weeks after injection, and spinal cord cross-sections were labeled with the nuclear fluorescent dye 
Hoechst 33342 (panels B,E,I) and immunostained with the MN marker SMI32 (panel H), and then observed 
with a fluorescence stereo-microscope (panels A–F) or a confocal microscope (panels G–J). Low-resolution 
stereo-microscopy images show a diffuse expression of both fluorescent Ca2+ probes (green signal, panels 
A,D,G), indicating that the cameleons are effectively transduced and expressed in the spinal cord in vivo. The 
merged reconstruction of complete z-stacks of cells collected by confocal microscopy shows that the D4ER 
cameleon is expressed only in SMI32-immunopositive MNs (merged image, panel J), suggesting the cell-specific 
expression of the probe. Scale bars = 200 µm (A–C), 100 µm (D–F), 10 µm (G–J).
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26/2014) laws concerning the care and use of laboratory animals. All experimental procedures and animal care 
protocols were approved by the Italian Ministry of Health (authorization N. 305/2017-PR), and by the Ethical 
Committee for animal care and use of the University of Padova (OPBA). All efforts were made to minimize ani-
mal suffering and reduce the number of animals used in the experiments.
Primary cultures. Primary MN cultures were established from E12.5 mouse embryos according to the 
Henderson’s protocol (Mettling et al.)40. Briefly, spinal cords were dissected from individual embryos in Hybernate 
medium (Gibco) added with 2% (v/v) B27 supplement (Gibco), and tissue was cut (<1 mm pieces) and incubated 
(8 min, 37 °C) in a buffer containing NaCl (124 mM), KCl (5.4 mM), NaH2PO4 (1 mM), glucose (3.6 mM), HEPES 
(25 mM, pH 7.4), added with BSA [0.3% (w/v)] and trypsin [0.025% (w/v)].
Then, cells were gently dissociated in a buffer made of Leibovitz’s medium (L15, Gibco) supplemented with 
sodium bicarbonate [7.5% (w/v)], horse serum [HS, 2% (v/v)], glucose [7.2% (w/v)], progesterone [0.1% (w/v)], 
insulin [1% (w/v)], putrescine [1% (w/v)], conalbumin [1% (w/v)], sodium selenite [0.1% (w/v)], BSA [0.4% 
(w/v)] and DNase I [0.1 mg/ml].
The cell suspension was then centrifuged (500 × g, 5 min, RT) over a cushion of BSA [4% (w/v)] (in the above 
medium), after which cells were recovered from the bottom of the tube, resuspended in a MN culture medium 
consisting of Neurobasal medium (Gibco) supplemented with HS [2% (v/v)], B27 [2% (v/v)], L-glutamine 
(0.05 mM), glutamate (25 µM), mercaptoethanol (25 µM), BDNF (10 ng/ml), GDNF (10 ng/ml), CNTF (10 ng/ml), 
penicillin (100 U/ml), and streptomycin (100 µg/ml). Cells were then plated at a density of approximately 500,000 
cells/well in 12-wells culture plates containing (18 mm diameter) glass coverslips coated with poly-D-ornithine 
(1.5 µg/ml in sterilized bidistilled H2O, 2 h, RT) and then with laminin (3 µg/ml in L15 medium, 3 h, 37 °C in a 5% 
CO2 atmosphere), and grown (37 °C in a 5% CO2 atmosphere).
Primary cultures of cerebellar granule and cortical neurons were prepared as described in De Mario et al.41. 
Hippocampal neurons were prepared following the same procedures for cortical neurons, except that they were 
grown in Neurobasal medium added with foetal bovine serum [FBS, 10% (v/v)].
Primary cultures of spinal astrocytes were isolated from newborn mice and cultured as described previously 
in Martorana et al.42. Once the cultures reached the confluence, they were re-plated at the optimal density 80,000 
cells/well in 24-well plates containing glass coverslips and maintained in minimal essential medium (MEM, 
Gibco), supplemented with FBS [10% (v/v)], L-glutamine (2 mM), glucose [0.3% (w/v)] in phosphate buffered 
saline (PBS), penicillin (100 U/ml]), and streptomycin (100 µg/ml).
On day 2 from plating, all primary cultures were transduced with the AAV particles and used in experiments 
at different times depending on the cell type. For the transfection of cortical neurons and spinal astrocytes with 
plasmidic vectors, the Lipofectamine-2000 reagent (Gibco) was used, following the manufacturer’s instructions.
Immunocytochemistry. For immunocytochemical analysis, cells were firstly washed in ice-cold PBS, and 
fixed (20 min, RT) in paraformaldehyde [PFA, 4% (w/v)] in PBS. After washing in PBS, cells were permeabilized 
in PBS containing Triton X-100 [1 h, RT, 0.02% (w/v)] and then incubated (overnight, 4 °C) with the following 
primary antibodies [Ab, diluted in PBS containing 1% (w/v) BSA as indicated in parentheses]: anti-SMI32 mouse 
monoclonal (m) Ab (1:200, Covance, cat. n. SMI-32R & SMI-32P); anti-glial fibrillary acidic protein (GFAP) 
rabbit polyclonal (p) Ab (1:500, Dako, cat. n. Z0334); anti-microtubule-associated protein-2 (MAP-2) chicken 
pAb (1:1000, Abcam, cat. n. ab5392); anti-calreticulin rabbit pAb (1:50, Stressgen, cat. n. ADI-SPA-600-J); 
anti-GAPDH rabbit pAb (1:50, Santa Cruz Biotechnologies, cat. n. sc-25778); anti-Tom20 rabbit pAb (1:50, Santa 
Cruz Biotechnologies, cat. n. sc-11415). After extensive washings in PBS, cells were incubated (1 h, 37 °C) with 
the following secondary antibodies, depending on the used primary Ab: Alexa Fluor 555-conjugated anti-mouse 
IgG (1:500, Molecular Probes); rhodamine-conjugated (1:100, Dako) or Alexa Fluor 568-conjugated (1:200, 
Molecular Probes) anti-rabbit IgG; Alexa Fluor 568-conjugated anti-chicken IgG (1:500, Molecular Probes). Cell 
nuclei were counter-stained with Hoechst 33342 (5 μg/ml, Sigma), and coverslips were finally washed in PBS, 
mounted in montage solution [8% Mowiol 40–88 (Sigma) in glycerol and PBS (1:3 (v/v)], and observed with an 
inverted fluorescence microscope (Leica CTR6000) equipped with a computer-assisted charge-coupled camera 
(Orca Flash 4.0, Hamamatsu), or with a Leica TSC SP5 inverted confocal microscope system, equipped with a 
HCX PL APO 63× or 100× magnification, numerical aperture 1.40, oil immersion objective, which also allowed 
the acquisition and analysis of digital images by a dedicated software (Leica AS). When indicated in the figure 
legends, cell images were reported as the merge of a complete z-stack of the observed field.
Ca2+ imaging. For Ca2+ imaging with the cameleon probes, 12 days after plating cells were mounted 
into an open-topped chamber and maintained under perfusion with a Krebs-Ringer buffer (KRB; in mM: 
NaCl 125, KCl 5, KH2PO4 0.4, MgSO4 1, glucose 5.5, HEPES 20; pH 7.4) containing CaCl2 (2 mM), through a 
temperature-controlled (37 °C) instrument (TC-324B, Warner Instruments,). Cells were stimulated with AMPA 
(Tocris, 25 μM) for cytosolic and mitochondrial Ca2+ measurements, or with 100 μM caffeine for ER Ca2+ meas-
urements (both stimuli were carried out in KRB).
Cell were analysed using a DM6000 inverted microscope (Leica) with a 40× oil objective (HCX Plan Apo, 
NA 1.25). Excitation light produced by a led (LZ1-00UA00-LED, Led Engin) was filtered at the appropriate 
wavelength (425 nm) through a band-pass filter, and the emitted light was collected through a dichroic mir-
ror (515 DCXR, Chroma Technologie), and a beam-splitter (OES) with emission filters (Chroma Technologies) 
HQ 480/40 M (for CFP) and HQ 535/30 M (for YFP). The beam-splitter permits the collection of the two emit-
ted wavelengths at the same time, thus preventing any artefact due to uncontrolled movement of the recording 
chamber and/or intracellular organelles. Images were acquired using an IM 1.4 C cooled CCD (Jenoptik Optical 
Systems) attached to a 12-bit frame grabber. Synchronization of the excitation source and the CCD was performed 
through a control unit ran by a custom-made software package (developed by C. Ciubotaru, Venetian Institute of 
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Molecular Medicine, Padova, Italy), which was also used for image acquisition, with an exposure time of 100 ms. 
The software recorded with-time variations (sampling rate = 1 s−1) of the ratio (R) between the acceptor and the 
donor fluorescence intensity, which was taken as a relative measurement of Ca2+ concentration. Peak values of 
Ca2+ transients were reported as the difference between the peak and the baseline R value (ΔR = Rpeak − Rbaseline).
In vivo AAV-mediated delivery of cameleons. For in vivo delivery of AAV vectors, we have used P1 mice, 
in light of previous reports demonstrating much higher transduction rates in newborns than in adult mice43, 44. 
After anaesthesia by topical administration of lidocaine, neonatal hSOD1(WT)-expressing mice (P1) received 
50 μl of viral suspension containing 3 × 1011 GC/ml of AAV9-Hb9_AB-4mtD3cpv or AAV9-Hb9_AB-D4ER, 
or vehicle (PBS), into the temporal vein using a Hamilton syringe with a 32-gauge needle. The injections were 
performed in a Biosafety Level 2 (BL2) laboratory.
Four weeks after the injection, animals were anesthetized by CO2 before killing by cervical dislocation, and 
spinal cords were collected and successively fixed in PFA [24 h, 4 °C, 4% (w/v)]. Fixed tissues were transferred 
to sucrose [30% (w/v) in PBS, overnight, 4 °C] for cryoprotection. 20 μm-thick sections were serially cut on a 
cryostat (Leica Microsystems), immunostained for the MN marker SMI32 and counter-stained with the nuclear 
dye Hoechst 33342, as described previously for immunocytochemical analyses. Finally, slices were mounted in 
montage solution on a glass coverslip, and observed with a fluorescence stereo-microscope (Leica M205-FA), or 
with the above described inverted confocal microscope system.
Statistical analysis. Off-line analysis of FRET data was performed with the ImageJ software. YFP and CFP 
images were subtracted for the respective background signals, and distinctly analysed after choosing proper 
regions of interest on selected cells. Subsequently, the ratio between YFP and CFP emission fluorescence intensity 
(F) was calculated (R = F535/F480) and reported as %. All the data are representative of at least n (indicated in the 
figures and/or figure legends) independent experiments, and are reported as mean ± standard error of the mean 
(SEM). Statistics were performed by unpaired Student’s t test, with a p value < 0.05 being considered statistically 
significant.
For mouse genotyping, NSC-34 cell culturing, and methods for Western blot analysis and Fura-2-based Ca2+ 
measurements, see Supplementary Information.
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